CDSCO approves ‘Palivizumab’, a long-awaited preventive therapy for Respiratory Syncytial Virus September 30, 2023 AstraZeneca Pharma India on Saturday announced the marketing approval from Central Drugs Standard Control Organisation (CDSCO) to import and market ‘Palivizumab’ injection 100 mg/ml (r-DNA origin) (50mg/0.5mL &... Trending AIIMS starts centralized sample collection, report distribution Diarrhea main killer of kids under 5, adults above 70: Study EU flagged cancer-causing chemicals in 527 Indian food products Latest Diarrhea main killer of kids under 5, adults above 70: Study Healthy population fuels productivity, drives economic growth: Union Health Secretary NEET-UG exam soon to shift from offline to online, NTA to undergo re-structuring What is textationship: New age Romance of New Generation
